Display options
Cite
Panchanathan E, Ramanathan G, Lakkakula BV. Effect of flupirtine on the growth and viability of U373 malignant glioma cells. Cancer Biol Med. 2013;10(3):142-7doi: 10.7497/j.issn.2095-3941.2013.03.004.
Panchanathan, E., Ramanathan, G., & Lakkakula, B. V. (2013). Effect of flupirtine on the growth and viability of U373 malignant glioma cells. Cancer biology & medicine, 10(3), 142-7. https://doi.org/10.7497/j.issn.2095-3941.2013.03.004
Panchanathan, Elango, et al. "Effect of flupirtine on the growth and viability of U373 malignant glioma cells." Cancer biology & medicine vol. 10,3 (2013): 142-7. doi: https://doi.org/10.7497/j.issn.2095-3941.2013.03.004
Panchanathan E, Ramanathan G, Lakkakula BV. Effect of flupirtine on the growth and viability of U373 malignant glioma cells. Cancer Biol Med. 2013 Sep;10(3):142-7. doi: 10.7497/j.issn.2095-3941.2013.03.004. PMID: 24379989; PMCID: PMC3860341.
Copy Download .nbib Format: NLM
Share it on

Cancer Biol Med. 2013 Sep;10(3):142-7. doi: 10.7497/j.issn.2095-3941.2013.03.004.

Effect of flupirtine on the growth and viability of U373 malignant glioma cells.

Cancer biology & medicine

Elango Panchanathan, Gnanasambandan Ramanathan, Bhaskar Venkata Kameswara Subrahmanya Lakkakula

Affiliations

  1. Department of Pharmacology, Sri Ramachandra University, Chennai 600118, India.
  2. Department of Biomedical Sciences, Sri Ramachandra University, Chennai 600118, India.

PMID: 24379989 PMCID: PMC3860341 DOI: 10.7497/j.issn.2095-3941.2013.03.004

Abstract

OBJECTIVE: Flupirtine is a non-opioid analgesic without antipyretic or antiphlogistic properties but with favorable tolerability in humans. This analgesic also exhibits neuroprotective activities. Furthermore, flupirtine antagonizes glutamate- and NMDA-induced intracellular levels of Ca(2+) and counteracts the effects of focal cerebral ischemia. Although flupirtine has been used to relieve pain caused by different diseases and clinical procedures, information on the safety and efficacy of flupirtine is limited. The present study was conducted to investigate the neuroprotective effects of flupirtine on U373 malignant glioma (MG) cell lines.

METHODS: Cell viability and cell cycle analysis was performed by MTT assay and flow cytometry, respectively.

RESULTS: Variations in the growth of U373 MG cells in 5 mM N-methyl-D-aspartate (NMDA), 1 mM flupirtine, and combined treatment indicated the antagonistic effects of NMDA and flupirtine on MG cell lines. The variation in the percentage of gated cell population in different cell cycle phases showed significant variations after 48 h of treatment.

CONCLUSION: Flupirtine has neuroprotective effect of on U373 MG cells, which limits its use in the pain management of brain tumors. This property warrants further studies using animal models and large-scale clinical trials.

Keywords: Flupirtine; N-Methylaspartate; analgesics; glioma

References

  1. Postgrad Med J. 1987;63 Suppl 3:45-7 - PubMed
  2. Mech Ageing Dev. 1998 Mar 16;101(1-2):1-19 - PubMed
  3. J Neural Transm (Vienna). 1999;106(9-10):857-67 - PubMed
  4. Exp Neurol. 1997 Oct;147(2):518-24 - PubMed
  5. Arzneimittelforschung. 1985;35(1):67-74 - PubMed
  6. Postgrad Med J. 1987;63 Suppl 3:67-70 - PubMed
  7. Eur J Pharmacol. 1995 Dec 29;294(2-3):469-73 - PubMed
  8. Neurology. 2004 Mar 9;62(5):714-8 - PubMed
  9. Fortschr Med. 1994 Jul 10;112(19):282-6 - PubMed
  10. Arzneimittelforschung. 1985;35(1):60-7 - PubMed
  11. Curr Med Res Opin. 2008 Dec;24(12):3523-30 - PubMed
  12. Curr Med Res Opin. 1984;9(3):204-12 - PubMed
  13. Neuropharmacology. 2006 Aug;51(2):283-94 - PubMed
  14. Curr Med Res Opin. 1985;9(9):594-601 - PubMed
  15. Invest Ophthalmol Vis Sci. 1996 Feb;37(2):274-80 - PubMed
  16. Br J Pharmacol. 1989 Jul;97(3):835-42 - PubMed
  17. Am J Pathol. 2008 Nov;173(5):1496-507 - PubMed
  18. J Neurosci Res. 2000 May 1;60(3):388-400 - PubMed
  19. J Clin Pharm Ther. 2012 Feb;37(1):4-6 - PubMed
  20. J Anaesthesiol Clin Pharmacol. 2012 Apr;28(2):172-7 - PubMed
  21. Br J Pharmacol. 2012 Jul;166(5):1631-42 - PubMed
  22. Pain Med. 2008 Oct;9(7):939-49 - PubMed
  23. Postgrad Med J. 1987;63 Suppl 3:71-9 - PubMed
  24. Neurosci Lett. 1992 Sep 14;144(1-2):124-6 - PubMed
  25. J Neurochem. 1997 Jun;68(6):2371-7 - PubMed
  26. J Int Med Res. 1988 Sep-Oct;16(5):338-48 - PubMed
  27. Arzneimittelforschung. 1985;35(1):75-7 - PubMed

Publication Types